The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis

Arthritis and Rheumatism

Volumn 42, Issue 5, 1999, Pages 1010-1016

  Gonzalez, Segundo ^a   Martinez Borra, J ^a   Torre Alonso, J C ^b   Gonzalez Roces, S ^a   Sanchez Del Rio J ^a   Rodriguez Perez A ^a   Brautbar, Chaim ^c   Lopez Larrea C ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL MONTE NARANCO   (Spain)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

ADULT; ALLELES; ARTHRITIS, PSORIATIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; LINKAGE (GENETICS); MALE; POLYMORPHISM, GENETIC; PSORIASIS;

EID: 0032908107     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H     Document Type: Article

References (37)

1. Moll JMH, Wright V. Familial occurrence of psoriatic arthritis. Ann Rheum Dis 1973;32:181-201.
2. Eastmond CF. Genetics and HLA antigens. Baillieres Clin Rheumatol 1994;8:263-76.
3. Norris DA, Travers JB, Leung DYM. Lymphocyte activation in the pathogenesis of psoriasis. J Invest Dermatol 1997;109:1-4.
4. Brenner W, Gschnait F, Mayr WR. HLA-B13, B17, B37 and Cw6 in psoriasis vulgaris: association with the age of onset. Arch Dermatol Res 1978;262:337-9.
5. López-Larrea C, Torre-Alonso JC, Rodriguez Perez A, Coto E. HLA antigens in psoriatic arthritis subtypes of a Spanish population. Ann Rheum Dis 1990;49:318-9.
6. Gladman DD, Anhorn KAB, Schachter RK, Mervant H. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-92.
7. Gladman DD, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis: multivariate relative risk model. Arthritis Rheum 1995;38:845-50.
8. Espinoza LR. Psoriatic arthritis: further epidemiologic and genetic considerations. In: Gerber LH, Espinoza LR, editors. Psoriatic arthritis. Orlando (FL): Grunne & Stratton; 1985. p. 9-32.
9. Salvarani C, Macchioni PL, Zizzi F, Mantovani W, Rossi F, Baricchi R, et al. Clinical subgroups in Italian patients with psoriatic arthritis. Clin Exp Rheumatol 1989;7:391-6.
10. Ozawa A, Ohkido M, Inoko H, Ando A. Specific restriction fragment length polymorphism on the HLA-C region and susceptibility to psoriasis vulgaris. J Invest Dermatol 1988;90:402-5.
11. Green J, Montasser M, Low HC, Woodrow JC. Investigation of the association of a number of HLA antigens with psoriasis and psoriatic arthritis. Stat Med 1988;7:443-50.
12. Ashaina A, Akazaki S, Nakawaka H, Kuwata S, Tokunaga K, Ishibashi Y, et al. Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. J Invest Dermatol 1991;97:254-8.
13. Mallon E, Bunce M, Wojnarowska F, Welsh K. HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics. J Invest Dermatol 1997;109: 183-6.
14. Roitberg-Tamburg A, Friedmann A, Tzfoni E, Battat S, Hammo R, Safirman C, et al. Do specific pockets of HLA-C molecules predispose Jewish patients to psoriasis vulgaris? J Am Acad Dermatol 1994;31:964-8.
15. Trabace S, Cappellacci S, Ciccarone P, Liaskos S, Polito R, Zorzin L. Psoriatic arthritis: a clinical radiological and genetic study of 58 Italian patients. Acta Derm Venereol Suppl (Stockh) 1994;186:69-70.
16. Schmitt-Egenolf M, Boehncke WH, Stander M, Eiermann TH, Sterry W. Oligonucleotide typing reveals association of type I psoriasis with HLA-DRB1*0701/2, -DQA1*0201, -DQB1*0303 extended haplotype. J Invest Dermatol 1993;100:749-52.
17. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994;91:6259-63.
18. Fodil N, Laloux L, Wanner V, Pellet P, Hauptmann G, Mizuki N, et al. Allelic repertoire of the human MHC class I MICA gene. Immunogenetics 1996;44:351-7.
19. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet's disease. Proc Natl Acad Sci U S A 1997;94:1298-303.
20. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 1998; 279:1737-40.
21. Torre-Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, López-Larrea C. Psoriatic arthritis: a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991;30:245-50.
22. Terasaki PI, Park MS. Microdroplet lymphocyte cytotoxicity test: manual of tissue typing techniques. Ray, JC, Hare, DS, Pedersen, PD, editors. OHEW Publications, NIH; Washington, DC. 1986. p. 69-80.
23. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours an alternative to serological DR typing in clinical practice including donorrecipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
24. Woolf B. On estimating the relation between blood groups and disease. Ann Hum Genet 1955;19:251-3.
25. Kleinbaum DG, Kupper LL, Morgenstern H. Measures of potential impact and summary of the measures. In: Epidemiologic research. New York: Van Nostrand Reinhold; 1982. p. 159-72.
26. Gonzalez-Roces S, Brautbar CH, Peña M, Dominguez O, Coto E, Alvarez V, et al. Molecular analysis of HLA-B27 in Jewish and Spanish populations. Hum Immunol 1994;41:127-34.
27. Prasad VK, Yang SY. Allele assignment for HLA-A,-B,-C genes to the Tenth International Histocompatibility Workshop cell lines. Tissue Antigens 1996;47:538-46.
28. Gonzalez-Roces S, Alvarez MV, Gonzalez S, Dieye A, Makni H, Woodfield DG, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997;49: 116-23.
29. Bunce M, Fanning GC, Welsh KI. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens 1995;45:81-90.
30. Ota M, Katsuyama Y, Mizuki N, Ando H, Furihata K, Ono S, et al. Trinucleotide repeat polymorphism within exon 5 of the MICA gene: allele frequency data in the nine population groups: Japanese, Northern Han, Hui, Uygur, Kazakhastan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 1997;49:448-54.
31. Tsuchiya N, Shiota M, Moriyama S, Ogawa A, Komatsu-Wakui M, Mitsui H, et al. MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypes. Arthritis Rheum 1998;41:68-73.
32. Goto K, Ota M, Ohno S, Mizuki N, Ando H, Katsuyama Y, et al. MICA gene and ankylosing spondylitis: linkage analysis via a transmembrane-encoded triplet repeat polymorphism. Tissue Antigens 1997;49:503-7.
33. Degli-Eposti MA, Leaver AL, Christiansen FT, Witt CS, Abraham LJ, Dawkins RI. Ancestral haplotypes conserved population MHC haplotypes. Hum Immunol 1992;34:242-52.
34. Tomfohrde J, Silverman A, Barnes R, Fernandez-Viña MA, Young M, Lory D, et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17p. Science 1994;264:1141-5.
35. FitzGerald O, Kane D. Clinical, immunopathogenic, and therapeutic aspects of psoriatic arthritis. Curr Opin Rheumatol 1997;9: 295-301.
36. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens. Immunol Today 1995;16:145-9.
37. Schatteman L, Mielants H, Veys EM, Cuvelier C, De Vos M, Gyselbrecht L, et al. Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. J Rheumatol 1995;22:680-3.